Insulet | PODD - Ebitda

Precio De Mercado
230.29
Cambio Diario
-0.20 -0.09%
Mensual
-7.55%
Anual
-13.37%
Q1 Expectativa
213.20




Ebitda Cambio Fecha
Abbott USD 3.09B 44M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
Cardinal Health USD 981M 5M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
ICU Medical USD 98.19M 27.67M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
J&J USD 9.52B 389M 2025-09
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Solventum Corp USD 437M 38M 2025-12
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
West Pharmaceutical Services USD 218.5M 5.4M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12